Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIB Study to Evaluate Primaquine Safety and Tolerability for Radical Cure of Uncomplicated Plasmodium Vivax Malaria in Children < 15 Years-old (CHILDPRIM)

NCT05044637 is registered in ClinicalTrials.gov with Fundação de Medicina Tropical Dr. Heitor Vieira Dourado as lead sponsor.

NCT NCT05044637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05044637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIB Study to Evaluate Primaquine Safety and Tolerability for Radical Cure of Uncomplicated Plasmodium Vivax Malaria in Children < 15 Years-old (CHILDPRIM)
Lead sponsor
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Phase
Phase 2
Overall status
Completed
Start date
August 26, 2021
Completion date
January 7, 2025
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, vivax